{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:53:04Z","timestamp":1784735584045,"version":"3.55.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication during ovarian stimulation. Even though the incidence of OHSS was relatively low in clinical practice, the consequence can be potentially devastating and life-threatening. Abnormal lipid metabolism may relate to the pathological development of OHSS, but there is still a research gap in the lipidomic research. So here in our study, an ultra-high-performance liquid chromatography coupled with electrospray ionization high-resolution mass spectrometry (UHPLC-ESI-HRMS) based lipidomic analysis was performed using follicular fluid samples obtained from 17 patients undergoing OHSS. The lipid profiles of OHSS patients were characterized by increased cholesterol ester (ChE) and decreased lysophosphatidylcholine (LPC), phosphatidylinositol (PI), sphingomyelin (SM), dimethylphosphatidylethanolamine (dMePE) and lysodimethylphosphatidylethanolamine (LdMePE). Totally 10 lipids including LPC(18:0), SM(d18:1\/16:0), PC(18:0\/18:1), PC(20:2\/20:5), PC(16:0\/18:1), TG(16:0\/18:1\/18:1), TG(16:0\/18:2\/18:2), TG(16:0\/16:1\/18:1), ChE(20:4) and TG(8:0\/8:0\/10:0) were selected as differential lipids. In conclusion, this study demonstrated the alteration of various lipids in OHSS patients, which suggested the key role of lipids during the development of OHSS and shed light on the further pathophysiological research of OHSS.<\/jats:p>","DOI":"10.3389\/fendo.2022.895116","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T04:29:36Z","timestamp":1656476976000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Lipid Analysis of Follicular Fluids by UHPLC-ESI-HRMS Discovers Potential Biomarkers for Ovarian Hyperstimulation Syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Yue","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.05.092","article-title":"Factors Associated With Ovarian Hyperstimulation Syndrome (OHSS) and its Effect on Assisted Reproductive Technology (ART) Treatment and Outcome","volume":"94","author":"Luke","year":"2010","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-017-0990-7","article-title":"What is the Best Predictor of Severe Ovarian Hyperstimulation Syndrome in IVF? A Cohort Study","volume":"34","author":"Tarlatzi","year":"2017","journal-title":"J Assisted Reprod Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a138598","article-title":"Early and Late Presentation of the Ovarian Hyperstimulation Syndrome: Two Distinct Entities With Different Risk Factors","volume":"9","author":"Lyons","year":"1994","journal-title":"Hum Reprod (Oxford)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)60047-8","article-title":"Outcome of IVF Pregnancies Following Severe OHSS","volume":"19","author":"Raziel","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1472-6483(10)60039-9","article-title":"Symposium: Update on Prediction and Management of OHSS Introduction","volume":"19","author":"Nardo","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"B6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S1472-6483(10)60042-9","article-title":"A Modern Classification of OHSS","volume":"19","author":"Golan","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"B7","first-page":"11","article-title":"Update on Ovarian Hyperstimulation Syndrome: Part 1 - Incidence and Pathogenesis","volume":"52","author":"Binder","year":"2007","journal-title":"Int J Fertil Womens Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-010-9387-6","article-title":"Ovarian Hyperstimulation Syndrome: Pathophysiology and Prevention","volume":"27","author":"Nastri","year":"2010","journal-title":"J Assisted Reprod Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)53348-2","article-title":"Severe Ovarian Hyperstimulation Syndrome Using Agonists of Gonadotropin-Releasing Hormone for In Vitro Fertilization: A European Series and a Proposal for Prevention","volume":"53","author":"Forman","year":"1990","journal-title":"Fertil steril"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0396-y","article-title":"TGF-\u03b21 Induces VEGF Expression in Human Granulosa-Lutein Cells: A Potential Mechanism for the Pathogenesis of Ovarian Hyperstimulation Syndrome","volume":"52","author":"Cheng","year":"2020","journal-title":"Exp Mol Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2019.5.15","article-title":"Serum Progesterone Concentrations On The Day Of Oocyte Retrieval Above 9.23 Ng\/Ml May Predict Ovarian Hyperstimulation Syndrome Risk In In Vitro Fertilized Patients","volume":"70","author":"Issat","year":"2019","journal-title":"J Physiol Pharmacol"},{"key":"B12","article-title":"High Levels Of Soluble Vascular Endothelial Growth Factor Receptor 1\/Sflt1 And Low Levels Of Vascular Endothelial Growth Factor In Follicular Fluid On The Day Of Oocyte Retrieval Correlate With Ovarian Hyperstimulation Syndrome Regardless Of The Stimulation Protocol","volume":"68","author":"Jakimiuk","year":"2017","journal-title":"J Physiol Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)60452-X","article-title":"How to Avoid Ovarian Hyperstimulation Syndrome: A New Indication for Dopamine Agonists","volume":"18","author":"Garcia-Velasco","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/01.ogx.0000314815.40384.a4","article-title":"Serum Anti-Mullerian Hormone and Estradiol Levels as Predictors of Ovarian Hyperstimulation Syndrome in Assisted Reproduction Technology Cycles","volume":"23","author":"Leeh","year":"2008","journal-title":"Hum Reprod"},{"key":"B15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13048-020-00624-9","article-title":"Comparative Analysis of Abdominal Fluid Cytokine Levels in Ovarian Hyperstimulation Syndrome (OHSS)","volume":"13","author":"Farkas","year":"2020","journal-title":"J Ovarian Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/srep19093","article-title":"Pharmacologic Interventions in Preventing Ovarian Hyperstimulation Syndrome: A Systematic Review and Network Meta-Analysis","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.11.005","article-title":"Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"101","author":"Leitao","year":"2014","journal-title":"Fertil Steril"},{"key":"B18","doi-asserted-by":"publisher","first-page":"CD006105","DOI":"10.1002\/14651858.CD006105.pub3","article-title":"Metformin Treatment Before and During IVF or ICSI in Women With Polycystic Ovary Syndrome","volume":"11","author":"Tso","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.09.046","article-title":"Calcium Infusion for the Prevention of Ovarian Hyperstimulation Syndrome: A Double-Blind Randomized Controlled Trial","volume":"103","author":"El-Khayat","year":"2015","journal-title":"Fertil Steril"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(00)00452-8","article-title":"Intravenous Albumin Versus Hydroxyethyl Starch for the Prevention of Ovarian Hyperstimulation in an in-Vitro Fertilization Programme: A Prospective Randomized Placebo Controlled Study","volume":"96","author":"Gokmen","year":"2001","journal-title":"Eur J Obstetrics Gynecology Reprod Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.3390\/ijms20194781","article-title":"The Need for Multi-Omics Biomarker Signatures in Precision Medicine","volume":"20","author":"Olivier","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gar047","article-title":"Development of Ovarian Hyperstimulation Syndrome: Interrogation of Key Proteins and Biological Processes in Human Follicular Fluid of Women Undergoing In Vitro Fertilization","volume":"17","author":"Jarkovska","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6604","article-title":"A Proteomic Analysis Identifies Candidate Early Biomarkers to Predict Ovarian Hyperstimulation Syndrome in Polycystic Ovarian Syndrome Patients","volume":"16","author":"Wu","year":"2017","journal-title":"Mol Med Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2003.11.002","article-title":"Lipidomics is Emerging","volume":"1634","author":"Lagarde","year":"2003","journal-title":"Biochim Et Biophys Acta-Molecular Cell Biol Lipids"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1776","article-title":"The Emerging Field of Lipidomics","volume":"4","author":"Wenk","year":"2005","journal-title":"Nat Rev Drug Discovery"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.12.026","article-title":"Lipidomics as an Emerging Tool to Predict Endometrial Receptivity","volume":"99","author":"Vilella","year":"2013","journal-title":"Fertil Steril"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e46059","DOI":"10.1371\/journal.pone.0046059","article-title":"Interaction Between Lysophosphatidic Acid, Prostaglandins and the Endocannabinoid System During the Window of Implantation in the Rat Uterus","volume":"7","author":"Sordelli","year":"2012","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)60006-5","article-title":"Luteal Phase Rescue in High-Risk OHSS Patients by GnRHa Triggering in Combination With Low-Dose HCG: A Pilot Study","volume":"18","author":"Humaidan","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.08.048","article-title":"Prevention and Treatment of Moderate and Severe Ovarian Hyperstimulation Syndrome: A Guideline","volume":"106","year":"2016","journal-title":"Fertil steril"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deq388","article-title":"Advanced Glycation End-Products Accumulation Compromises Embryonic Development and Achievement of Pregnancy by Assisted Reproductive Technology","volume":"26","author":"Jinno","year":"2011","journal-title":"Hum Reprod"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-017-0483-7","article-title":"Optimization of Lipid Extraction and Analytical Protocols for UHPLC-ESI-HRMS-Based Lipidomic Analysis of Adherent Mammalian Cancer Cells","volume":"409","author":"Zhang","year":"2017","journal-title":"Anal Bioanal Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00793","article-title":"Lipid Profiling of Peri-Implantation Endometrium in Patients With Premature Progesterone Rise in the Late Follicular Phase","volume":"104","author":"Li","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5935\/1518-0557.20160009","article-title":"Human Follicular Fluid and Effects on Reproduction","volume":"20","author":"Basuino","year":"2016","journal-title":"J Bras Reprod Assist"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-020-01860-0","article-title":"Extracellular microRNA Profiling in Human Follicular Fluid: New Biomarkers in Female Reproductive Potential","volume":"37","author":"Qasemi","year":"2020","journal-title":"J Assisted Reprod Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13048-019-0572-7","article-title":"Effect of Endometrioma Cystectomy on Cytokines of Follicular Fluid and IVF Outcomes","volume":"12","author":"Liang","year":"2019","journal-title":"J Ovarian Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/s41598-018-35379-3","article-title":"Extracellular microRNAs Profile in Human Follicular Fluid and IVF Outcomes","volume":"8","author":"Martinez","year":"2018","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1530\/REP-16-0641","article-title":"Melatonin Levels in Follicular Fluid as Markers for IVF Outcomes and Predicting Ovarian Reserve","volume":"153","author":"Tong","year":"2017","journal-title":"Reprod"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-015-8633-2","article-title":"Optimizing the Lipidomics Workflow for Clinical Studies-Practical Considerations","volume":"407","author":"Hyotylainen","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-015-0592-1","article-title":"Lipidomics Analysis of Follicular Fluid by ESI-MS Reveals Potential Biomarkers for Ovarian Endometriosis","volume":"32","author":"Cordeiro","year":"2015","journal-title":"J Assisted Reprod Genet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.491892","article-title":"Lipid Metabolic Disorders and Ovarian Hyperstimulation Syndrome: A Retrospective Analysis","volume":"11","author":"Liu","year":"2020","journal-title":"Front Physiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-002-0384-9","article-title":"Lipoprotein Lipase: Structure, Function, Regulation, and Role in Disease","volume":"80","author":"Mead","year":"2002","journal-title":"J Mol Med-Jmm"},{"key":"B42","article-title":"Correlation Between the Level of Cholesteryl Ester Transfer Protein in Follicular Fluid With Fertilization Rates in IVF\/ICSI Cycles","volume":"9","author":"Mehdizadeh","year":"2011","journal-title":"Iranian J Reprod Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2018.08.005","article-title":"Inflammatory Markers in Human Follicular Fluid Correlate With Lipid Levels and Body Mass Index","volume":"130","author":"Gonzalez","year":"2018","journal-title":"J Reprod Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.3390\/molecules22111964","article-title":"Phospholipids of Animal and Marine Origin: Structure, Function, and Anti-Inflammatory Properties","volume":"22","author":"Lordan","year":"2017","journal-title":"Molecules"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545676","article-title":"The Regulation of Inflammation by Oxidized Phospholipids","volume":"46","author":"Freigang","year":"2016","journal-title":"Eur J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11306-018-1350-z","article-title":"Hyper Response to Ovarian Stimulation Affects the Follicular Fluid Metabolomic Profile of Women Undergoing IVF Similarly to Polycystic Ovary Syndrome","volume":"14","author":"Cordeiro","year":"2018","journal-title":"Metabolomics"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaw065","article-title":"Sphingosine-1-Phosphate Restores Endothelial Barrier Integrity in Ovarian Hyperstimulation Syndrome","volume":"22","author":"Scotti","year":"2016","journal-title":"Mol Hum Reprod"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.895116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T04:29:40Z","timestamp":1656476980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.895116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":47,"alternative-id":["10.3389\/fendo.2022.895116"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.895116","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"article-number":"895116"}}